A double blind clinical trial on the efficacy of honey drop in vernal keratoconjunctivitis.
Purpose. This trial was designed to evaluate the efficacy and safety of topical honey eye drops in patients with diagnosed VKC. Methods. This clinical trial was conducted on 60 patients with diagnosed VKC. The patients were selected and randomly allocated between two groups of 30. Patients in two groups received honey eye drop (60% in artificial tear) or placebo, other than cromolyn and fluorometholone 1% eye drops, to be used topically in each eye, four times per day. The patients were examined with slit lamp and torch at baseline and the follow-up visits on the 1st, 3rd, and 6th months of the study for redness, limbal papillae, and intraocular pressure. Results. Out of 60 patients who completed the study, 19 patients (31.7%) were female. There was significant increase in eye pressure and reduction in redness as well as limbal papillae, following the consumption of the honey drop in honey group compared to placebo control group (P < 0.05). At the end of trial, one patient in honey group and 7 ones in placebo group had limbal papillae (P < 0.05). Conclusion. Topical honey eye drops, when used along with Cromolyn and Fluorometholone eye drops, might be beneficial for the treatment of VKC.
Feiz Hospital-Ophthalmology Center, Isfahan University of Medical Sciences, Qods Square, Isfahan, Iran.
Ali
A
Salehi
Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Solmaz
S
Jabarzare
Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mohammadreza
M
Neurmohamadi
Clinical Biochemistry Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Soleiman
S
Kheiri
Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mahmoud
M
Rafieian-Kopaei